- Research
- Open access
- Published:
Relative fat mass as a predictor of gallstones: insights from national health and nutrition examination survey data
Lipids in Health and Disease volume 24, Article number: 78 (2025)
Abstract
Background
Gallstones have been linked to obesity. Relative fat mass (RFM) has emerged as a novel obesity index that more precisely represents the body fat distribution. The correlation between RFM and the risk of developing gallstones remains unclear. This study aims to explore the correlation between RFM and the prevalence of gallstones.
Methods
A cross-sectional analysis was conducted on the data from the NHANES 2017–2020. The correlation between RFM and the formation of gallstones was examined through multivariate logistic regression, receiver operating characteristic (ROC) curve, sensitivity analysis, subgroup analysis, and restricted cubic spline regression.
Results
Among the 12,947 subjects, 1362 were categorized as having gallstones. It was observed that as the quartile range of RFM increased, with a notable rise in the prevalence of gallstones (3.7% vs. 7.5% vs. 9.8% vs. 21.1%, P < 0.001). Logistic and RCS regression analyses indicated a significantly positive linear correlation between RFM and the prevalence of gallstones, even after accounting for confounders potential (adjusted OR = 1.075, 95% CI: 1.050, 1.101). There is still a significant correlation between RFM and the prevalence of gallstones across both subgroup and sensitivity analyses. ROC analysis indicated that RFM (AUC = 0.696, 95%CI: 0.682, 0.711) can serve as a more robust identify for developing gallstones compared to traditional anthropometric indices.
Conclusion
This study is the first to provide the evidence of a significantly positive correlation between RFM and the formation of gallstones. However, further prospective studies are needed to validate these findings.
Introduction
Gallstone is one of the most prevalent digestive diseases worldwide, and the risk factors have been well established for gallbladder cancer as well. Gallstone represents a substantial healthcare burden in the United States, impacting up to 15% of its population [1, 2]. Epidemiological data indicate that the prevalence of gallstones ranges from 10 to 15% among Caucasian adults, which can be as high as 70% among American Indians [3, 4]. While gallstones are typically asymptomatic, 10–25% of affected individuals may experience specific symptoms such as acute cholecystitis and biliary pain. In these symptomatic cases, 1–2% may develop complications [5,6,7], which can lead to severe pain and potentially life-threatening conditions. Although previous studies have identified risk factors correlated with the formation of gallstones, there is still a lack of reliable clinical indexes to prevent gallstones.
Numerous studies have identified obesity as a significant risk factor for developing of gallstones [8,9,10]. Obesity is typically characterized by the excessive accumulation of adipose tissues, which has a detrimental effect on physical health [11, 12]. Currently, the most commonly used criteria for obesity include waist-to-height ratio (WHtR), body mass index (BMI), waist-to-hip ratio (WHR), and waist circumference (WC). However, these traditional obesity indices primarily reflect the degree of overweight and abdominal obesity, without distinguishing between subcutaneous and visceral fat [13]. To address this limitation, researchers recently proposed and validated a simple and cost-effective method to estimate the whole-body fat percentage in adults: relative fat mass (RFM) [14]. RFM incorporates height, gender, and WC, and has been shown to better predict and estimate whole-body fat percentage than BMI among both females and males. Additionally, RFM demonstrated relatively good accuracy across diverse populations, including African-Americans, European-Americans, and Mexican-Americans [14]. Furthermore, RFM has been correlated with various diseases, including coronary heart disease [15], thromboembolism [16], type 2 diabetes [17], and hypertension [18].
However, the correlation between developing gallstones and RFM remains unclear. Additionally, it is still difficult to determine the best anthropometric index for gallstone screening. This study aims to explore the correlation between RFM and developing gallstones according to the data from NHANES. Additionally, it compared the correlations of BMI, WC, weight-adjusted waist circumference index (WWI), WHtR, and body roundness index (BRI) with the formation of gallstones, thereby evaluating the strength of the correlation between RFM and developing gallstones.
Methods
Research subjects
NHANES, conducted by NCHS [19], is a comprehensive study designed to assess the correlation between nutrition, health promotion, and disease prevention. The survey is conducted biennially on dietary, demographic, examination, and laboratory data by taking physical examinations, interviews, and various sections. Additional information regarding the NHANES database can be found at http://www.cdc.gov/nhanes.
The baseline clinical data analyzed in this study were derived from NHANES 2017–2020. Subjects aged 20 years old and older (n = 14801) were included in this study. And according to the exclusion criteria, subjects lacking data of RFM (n = 1817), those without questionnaire on gallstones (n = 37), were excluded. Consequently, 12,947 subjects were included in this study, of whom 1362 reported a history of developing gallstones by themselves (as shown in Fig. 1).
Measurement of covariates
According to previous studies [5, 14], potential confounding factors correlated with developing gallstones and RFM were incorporated into the final analysis. These factors included demographic variables (height, age, race, WC, gender, weight, educational attainment, and physical activities). Uric acid (UA), total cholesterol (TC), fasting plasma glucose (FPG), low-density lipoprotein cholesterol (LDL-C), albumin, triglycerides (TG), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), creatinine, aspartate aminotransferase (AST), and high-density lipoprotein cholesterol (HDL-C) were collected in blood samples. Questionnaire surveys included hypertension, alcohol consumption, diabetes mellitus, dietary intake factors, encompassing energy, fat, sugar, and water. All the participants from 2017 to 2020 completed 24-hour dietary recalls on the mean consumption rates derived from these two recalls. Less than 3% of values missed in total. Multiple imputation was performed for missing values. Detailed measurement methodologies and data acquisition for each variable can be accessed at www.cdc.gov/nchs/nhanes.
Calculation formula of anthropometric index
Fundamental anthropometric parameters, including height, WC, and weight, were assessed through standardized methodologies and instruments at the mobile examination center. Subsequently, indices such as RFM, BMI, WtHR, BRI, and WWI, were calculated through established formulas as follows:
RFM = 64−(20×height/WC) + (12×gender), gender = 0 for male and 1 for female.
BMI = weight (kg) / height2(m).
BRI = 364.2 − 365.5 × (1− [(WC (cm) / 2π) / (height(m) ×0.5)]2)0.5.
WWI = WC (cm) / Weight0.5(cm/kg0.5).
WtHR = WC (cm) / Height(cm).
Statistical analysis
Subjects were categorized into quartiles (Q1:≤29.8; Q2: 29.8–35.6; Q3: 35.6–43.6; Q4:>43.6) according to RFM values. Continuous variables were compared through T-test and the Mann-Whitney U test (for non-normal distributed variables), and Categorical variables were compared through Chi-squared test. ORs and 95% CIs between RFM and developing gallstones were explored with multiple logistic regression models. Variables demonstrating clinical and statistical significance through univariate analyses (p < 0.05) were incorporated into multivariate analyses. Differences between subjects grouped by quartiles of RFM were compared in multivariable logistic regression, with Q1 as the reference group. The analysis incorporated three models: Model 1 (unadjusted), Model 2 (adjusted for race, gender, and age), and Model 3 (further adjusted for BMI, alcohol abuse, education level, TC, moderate physical activities, diabetes mellitus, TG, albumin, PIR, hypertension, ALT, LDL-c, AST, creatinine, FPG, GGT, uric acid, total water, total energy, total sugar and total fat). The potential modification of covariates on correlation was explored through interaction tests and subgroup analyses. Furthermore, the non-linear correlation between RFM and developing gallstones was assessed through RCS analyses. Sensitivity analyses were performed after excluding individuals with extreme energy intake values (consuming more than 5000 kcal or less than 500 kcal per day). Additionally, Inverse Probability Weighting (IPW) regression analysis on the unweighted raw data was applied to address potential confounding variables. Finally, the diagnostic efficacy of RFM, WC, BMI, WHtR, WWI and BRI in detecting was evaluated through ROC curve analyses. The differences in AUC values were compared through the Delong test. Data analyses were performed with R software and Free Statistics software, with a significance threshold at P < 0.05 for all statistical tests.
Results
Clinical baseline features of subjects
Baseline demographic characteristics of enrolled subjects are detailed in Table 1, with attributes categorized according to gallstone status. Apart from alcohol intake, liver function, educational level, uric acid, HDL-C, PIR and dietary parameters (total water, sugar intake), significant differences in baseline characteristics were identified between the two cohorts. Subjects with gallstones demonstrated higher values in age, BMI, TG, FPG, WC, and RFM. Additionally, the proportion of females was significantly higher, and the prevalence of hypertension and diabetes mellitus was also higher in this group. Conversely, subjects with gallstones showed lower levels of creatinine, albumin, TC, total energy and total fat intake.
Increase of RFM was positively correlated with the incidence of gallstones
As illustrated in Fig. 2, the quartile range of RFM increased, with a notable rise in the prevalence of gallstones (3.7% vs. 7.5% vs. 9.8% vs. 21.1%, P < 0.001). In the multiple logistic regression analysis, a significantly positive correlation was found between RFM and gallstones after adjusting Model 3 for confounders (OR = 1.075, 95% CI: 1.050, 1.101). According to the sensitivity analysis, RFM was categorized into quartiles, showing that in the fully adjusted Model 3, subjects in the second, third, and fourth quartiles exhibited a statistically significant increase in the risk of developing gallstones by 0.683, 1.350, and 3.125, respectively, compared to those in the lowest quartile (as shown in Table 2). RCS analyses demonstrated a linear association between RFM and developing gallstones (as shown in Fig. 3).
Subgroup analysis
A stratified multivariate logistic regression analysis was performed to explore the correlation between RFM and gallstones, across diverse population subgroups (Fig. 4).
The interaction test revealed no statistically significant differences in the correlation between RFM and gallstones with respect to education level, moderate physical activity, age, gender, BMI, and disease status (including hypertension and diabetes). These findings indicate that these variables did not significantly influence the observed positive correlation (all P for interaction > 0.05).
Sensitivity analyses
The results of sensitivity analysis are presented in Table 3. After excluding individuals with extreme energy intake, OR for the prevalence of gallstones was 1.075 (95% CI: 1.050, 1.101). After IPW, OR for the prevalence of gallstones was 1.073 (95% CI: 1.040, 1.070).
Predictive value of RFM for gallstones
ROC curve in Fig. 5 shows the diagnostic performance of RFM, WC, BMI, WHtR, WWI and BRI in identifying gallstones. As demonstrated in Table 4, RFM exhibited the highest diagnostic accuracy for gallstones, with an AUC value of 0.696 (95% CI: 0.682–0.711), significantly exceeding other anthropometric indexes (P < 0.001).
Discussion
This cross-sectional study was conducted on the data from NHANES to evaluate the correlation between RFM and the prevalence of gallstones, indicating a positive correlation between RFM and the prevalence of gallstones. Furthermore, this positive correlation was consistent with that from subgroup and sensitivity analyses. RCS analysis demonstrated a linear correlation between RFM and the prevalence of gallstones. Moreover, ROC analysis indicated that RFM exhibited superior identify ability for developing gallstones compared to WC, BMI, WHtR, BRI, and WWI, with statistical significance.
Obesity is widely recognized as a significant risk factor for developing gallstones, a correlation substantiated by numerous epidemiological studies [20, 21]. Among various indexes of obesity, BMI reflecting overall adiposity, has been the most commonly used index in recent years. Several studies have demonstrated a positive correlation between BMI and the risk of developing gallstones, which aligns with the findings of this study [22]. WWI, an obesity assessment metric proposed by Park et al., is considered as a more practical and reasonable measure compared to BMI alone [23]. Consistent with this, a cross-sectional study revealed a positive correlation between higher WWI and the prevalence of gallstones [24]. Additionally, other commonly used obesity metrics include WHtR, BRI, and WC. However, these traditional measures have certain limitations. For instance, BMI does not account for the specific distribution of body fat, while WHtR and WC fail to differentiate between subcutaneous and visceral fat. Consequently, RFM was developed to estimate body fat distribution by incorporating height, WC, and gender. Multiple studies have demonstrated that RFM can accurately estimate whole-body fat percentage [18, 25,26,27]. In extensive cohorts from Brazil, United States, and Korea, adiposity measured by dual-energy X-ray absorptiometry (DXA) exhibited a stronger correlation with RFM than that with BMI [14, 26, 28]. Furthermore, RFM has been identified as a significant predictor in the evaluation of various health conditions, including diabetes [17], NAFLD [29], metabolic syndrome [30], hyperlipidemia [31], and heart failure [32]. In the alignment with prior research, the findings indicate that RFM can serve as a predictive tool for gallstones, demonstrating superior predictive capability compared to traditional anthropometric indices. Consequently, as a recently developed obesity metric, RFM holds considerable promise as a predictor for the occurrence of gallstones. Nevertheless, additional large-scale prospective cohort studies are necessary to validate these conclusions.
Obesity significantly increases the risk of developing gallstones through various pathophysiological mechanisms. Firstly, obesity contributes to heightened insulin resistance, which is correlated with a range of metabolic disorders elevating the incidence of gallstones [33]. Secondly, there is an overproduction of cholesterol resulting from the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity in individuals with obesity, thereby facilitating the formation of cholesterol gallstones [34]. Lastly, leptin, a hormone secreted by adipocytes, has been implicated in this process. Studies with mouse models have demonstrated that bile cholesterol saturation diminishes when these mice exhibit resistance to leptin [35]. Obesity is correlated with elevated leptin secretion, which subsequently leads to an increased secretion of cholesterol into the bile, thereby heightening the risk of developing gallstones [36].
In this study, a robust positive correlation between RFM and the prevalence of gallstones across various stratifications, including disease status, gender, BMI, and race, was observed with all interaction P-values exceeding 0.05. Furthermore, previous research has indicated that a high energy intake is associated with an increased risk of gallstones [37]. After excluding individuals with extreme energy intake, sensitivity analyses demonstrated that the positive correlation remained significant. These findings underscore that RFM is a reliable metric for assessing body fat distribution, suggesting that effective management of adiposity may potentially mitigate the progression of gallstone development. It is important to note that rapid weight loss is correlated with an increased risk of developing gallstones [38, 39]. Consequently, it is imperative to emphasize strategies for weight reduction that incorporate personalized weight loss programs and dietary modifications [40].
Study strengths and limitations
This study possesses several notable strengths. Firstly, the samples employed in this study were derived from NHANES, which is characterized by its extensive sample size and high-quality data. Secondly, this study considered multiple confounding variables and subgroup and sensitivity analyses were conducted to ensure the generalizability of the findings across different populations. Thirdly, the comparatively good diagnostic efficacy of RFM for identifying gallstones underscores its potential for clinical application. However, large-scale prospective studies are still needed to verify the results due to slightly small AUCs. Additionally, this study is subject to several limitations. Firstly, this study does not establish a causal relationship between RFM and the development of gallstones. Secondly, it did not account for the potential influences of hormonal levels and medication usage. Thirdly, the determination of gallstone presence or absence relied on self-reported questionnaires, rather than objective imaging studies, which introduces the possibility of recall bias. Consequently, further validation of the findings through imaging modalities such as MRI and CT are warranted.
Conclusion
This study identified a positive correlation between RFM and the prevalence of gallstones within American adults. Furthermore, RFM demonstrated superior identify capability for the occurrence of gallstones when compared to traditional anthropometric indices. This study aims to enhance public awareness regarding the significance of RFM, a novel metric for assessing obesity, and to underscore that maintaining a moderate RFM may contribute to a reduction in the incidence of gallstones. However, more prospective studies are needed to validate these findings.
Data availability
The datasets generated and analysis during the current study are available in the NHANES, www.cdc.gov/nchs/NHANEs/.
Change history
15 March 2025
The original online version of this article was revised: the authors noticed that affiliations were incorrectly presented and requested to update affiliations 1, 3 and 4.
15 March 2025
A Correction to this paper has been published: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-025-02519-4
References
Friedman GD. Natural history of asymptomatic and symptomatic gallstones. Am J Surg. 1993;165:399–404.
Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99–109.
Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6:172–87.
Figueiredo JC, Haiman C, Porcel J, Buxbaum J, Stram D, Tambe N, Cozen W, Wilkens L, Le Marchand L, Setiawan VW. Sex and ethnic/racial-specific risk factors for gallbladder disease. BMC Gastroenterol. 2017;17:153.
Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006;20:981–96.
Marschall HU, Krawczyk M, Grunhage F, Katsika D, Einarsson C, Lammert F. Gallstone disease in Swedish twins is associated with the Gilbert variant of UGT1A1. Liver Int. 2013;33:904–8.
Tanaka H, Imasato M, Yamazaki Y, Matsumoto K, Kunimoto K, Delpierre J, Meyer K, Zerial M, Kitamura N, Watanabe M, et al. Claudin-3 regulates bile canalicular paracellular barrier and cholesterol gallstone core formation in mice. J Hepatol. 2018;69:1308–16.
Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13:9–19.
Aune D, Norat T, Vatten LJ. Body mass index, abdominal fatness and the risk of gallbladder disease. Eur J Epidemiol. 2015;30:1009–19.
Banim PJ, Luben RN, Bulluck H, Sharp SJ, Wareham NJ, Khaw KT, Hart AR. The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk). Eur J Gastroenterol Hepatol. 2011;23:733–40.
Oliveros E, Somers VK, Sochor O, Goel K, Lopez-Jimenez F. The concept of normal weight obesity. Prog Cardiovasc Dis. 2014;56:426–33.
Safaei M, Sundararajan EA, Driss M, Boulila W, Shapi’i A. A systematic literature review on obesity: understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity. Comput Biol Med. 2021;136:104754.
Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11:11–8.
Woolcott OO, Bergman RN. Relative fat mass (RFM) as a new estimator of whole-body fat percentage horizontal line a cross-sectional study in American adult individuals. Sci Rep. 2018;8:10980.
Efe SC, Karagoz A, Dogan C, Bayram Z, Kalkan S, Altintas MS, Yuksel Y, Karabag T, Ayca B, Ozdemir N. Relative Fat Mass Index can be solution for obesity paradox in coronary artery disease severity prediction calculated by SYNTAX score. Postgrad Med J. 2021;97:434–41.
Caiano LM, Costanzo S, Panzera T, Di Castelnuovo A, de Gaetano G, Donati MB, Ageno W, Iacoviello L. Moli-Sani Study I: Association between body mass index, waist circumference, and relative fat mass with the risk of first unprovoked venous thromboembolism. Nutr Metab Cardiovasc Dis. 2021;31:3122–30.
Suthahar N, Wang K, Zwartkruis VW, Bakker SJL, Inzucchi SE, Meems LMG, Eijgenraam TR, Ahmadizar F, Sijbrands EG, Gansevoort RT, et al. Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population. Eur J Intern Med. 2023;109:73–8.
Yu P, Huang T, Hu S, Yu X. Predictive value of relative fat mass algorithm for incident hypertension: a 6-year prospective study in Chinese population. BMJ Open. 2020;10:e038420.
Jin X, Xu J, Weng X. Correlation between ratio of fasting blood glucose to high density lipoprotein cholesterol in serum and non-alcoholic fatty liver disease in American adults: a population based analysis. Front Med (Lausanne). 2024;11:1428593.
Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut. 2006;55:708–14.
Hsu HY, Huang CY, Hwang LC. Sex difference of the predictive value of BMI, waist circumference and percentage body fat mass for gallstone disease. Br J Nutr. 2019;121:955–60.
Bonfrate L, Wang DQ, Garruti G, Portincasa P: Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Pract Res Clin Gastroenterol. 2014;28:623–635
Park Y, Kim NH, Kwon TY, Kim SG. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Sci Rep. 2018;8:16753.
Ke B, Sun Y, Dai X, Gui Y, Chen S. Relationship between weight-adjusted waist circumference index and prevalence of gallstones in U.S. adults: a study based on the NHANES 2017–2020. Front Endocrinol (Lausanne). 2023;14:1276465.
Zhang J, Liang D, Xu L, Liu Y, Jiang S, Han X, Wu H, Jiang Y. Associations between novel anthropometric indices and the prevalence of gallstones among 6,848 adults: a cross-sectional study. Front Nutr. 2024;11:1428488.
Correa CR, Formolo NPS, Dezanetti T, Speretta GFF, Nunes EA. Relative fat mass is a better tool to diagnose high adiposity when compared to body mass index in young male adults: a cross-section study. Clin Nutr ESPEN. 2021;41:225–33.
Zhu X, Yue Y, Li L, Zhu L, Cai Y, Shu Y. The relationship between depression and relative fat mass (RFM): a population-based study. J Affect Disord. 2024;356:323–8.
Cichosz SL, Rasmussen NH, Vestergaard P, Hejlesen O. Is predicted body-composition and relative fat mass an alternative to body-mass index and waist circumference for disease risk estimation? Diabetes Metab Syndr. 2022;16:102590.
Shen W, Cai L, Wang B, Wang Y, Wang N, Lu Y. Associations of relative Fat Mass, a Novel Adiposity Indicator, with non-alcoholic fatty liver Disease and Cardiovascular Disease: data from SPECT-China. Diabetes Metab Syndr Obes. 2023;16:2377–87.
Kobo O, Leiba R, Avizohar O, Karban A. Relative fat mass (RFM) as abdominal obesity criterion for metabolic syndrome. Eur J Intern Med. 2019;63:e9–11.
Kobo O, Leiba R, Avizohar O, Karban A. Relative fat mass is a better predictor of dyslipidemia and metabolic syndrome than body mass index. Cardiovasc Endocrinol Metab. 2019;8:77–81.
Suthahar N, Meems LMG, Withaar C, Gorter TM, Kieneker LM, Gansevoort RT, Bakker SJL, van Veldhuisen DJ, de Boer RA. Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND. Sci Rep. 2022;12:147.
Cortes VA, Barrera F, Nervi F. Pathophysiological connections between gallstone disease, insulin resistance, and obesity. Obes Rev. 2020;21:e12983.
Lu XY, Shi XJ, Hu A, Wang JQ, Ding Y, Jiang W, Sun M, Zhao X, Luo J, Qi W, Song BL. Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis. Nature. 2020;588:479–84.
Tran KQ, Graewin SJ, Swartz-Basile DA, Nakeeb A, Svatek CL, Pitt HA. Leptin-resistant obese mice have paradoxically low biliary cholesterol saturation. Surgery. 2003;134:372–7.
Wang SN, Yeh YT, Yu ML, Dai CY, Chi WC, Chung WL, Lee KT. Hyperleptinaemia and hypoadiponectinaemia are associated with gallstone disease. Eur J Clin Invest. 2006;36:176–80.
Compagnucci AB, Perroud HA, Batalles SM, Villavicencio R, Brasca A, Berli D, Pezzotto SM. A nested case-control study on dietary fat consumption and the risk for gallstone disease. J Hum Nutr Diet. 2016;29:338–4.
Nakano S, Suzuki M, Haruna H, Yamataka A, Shimizu T. Gallstone formation due to rapid weight loss through hyperthyroidism. J Pediatr Endocrinol Metab. 2019;32:1395–8.
Yang H, Petersen GM, Roth MP, Schoenfield LJ, Marks JW. Risk factors for gallstone formation during rapid loss of weight. Dig Dis Sci. 1992;37:912–8.
Sulaberidze G, Okujava M, Liluashvili K, Tughushi M, Bezarashvili S. Dietary fiber’s benefit for gallstone disease prevention during rapid weight loss in obese patients. Georgian Med News 2014:95–9.
Acknowledgements
We would like to thank the NHANES database for providing the data source for this study.
Funding
This study was supported by the Wenzhou Municipal Science and Technology Bureau (Y2023377 to Lei Miao).
Author information
Authors and Affiliations
Contributions
LM designed the study; HL, SXY and JX collected biochemical data; XCL drafted the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The National Center for Health Statistics Ethics Review Board has approved the implementation of NHANES.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: the authors noticed that affiliations were incorrectly presented and requested to update affiliations 1, 3 and 4.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Lin, X., Lin, H., Xu, J. et al. Relative fat mass as a predictor of gallstones: insights from national health and nutrition examination survey data. Lipids Health Dis 24, 78 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-025-02480-2
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-025-02480-2